| Literature DB >> 35992662 |
Xiaoli Tang1,2,3, Gongsang Yangjing1,2, Gusang Zhuoma1,2, Xiaofang Guo3, Pengxi Cao3, Benlin Yi1,2, Wumei Wang3, Matias Pasquali4, Ivan Baccelli5, Quirico Migheli6, Xiaoyulong Chen1,2,3, Tomislav Cernava1,2,7.
Abstract
Wheat (Triticum aestivum L.) is an important cereal crop, widely grown throughout the temperate zones, and also suitable for cultivation at higher elevations. Fusarium head blight (FHB) is a highly destructive disease of wheat throughout the globe. In July 2020, serious wheat FHB symptoms were observed in open fields located in Linzhi City, southeast of Tibet, China. The causal agent was identified as Fusarium avenaceum (Fr.) Sacc. by amplification and sequencing of the internal transcribed spacer (ITS) region, translation elongation factor 1-alpha (EF-1α) gene, and RNA polymerase II subunit (RPB-2) gene, as well as by morphological characterization. Koch's postulates were confirmed by a pathogenicity test on healthy spikes, including re-isolation and identification. To our knowledge, this is the first report of F. avenaceum causing FHB on wheat in Tibet, China. Moreover, to determine pathogen characteristics that may be useful for future disease management, the utilization of different carbon and nitrogen resources, temperature, light, and ultraviolet (UV) irradiation on mycelium growth and conidia germination were studied. Soluble starch and peptone were the best carbon, and nitrogen source for the pathogen respectively. The optimal temperatures for the pathogen's mycelium growth and conidia germination were 15-20°C, matching the average temperature during the growing season in Linzhi (Tibet). Meanwhile, alternating 8-h light and 16-h dark was shown to be conducive to mycelia growth, and complete darkness facilitated conidia germination. In addition, UV Irradiation of 48 MJ/cm2, approximately 100 times of the local condition, did not inhibit the germination of conidia. Furthermore, in vitro screening of effective fungicides was conducted. Among the seven tested pesticides, carbendazim showed the best inhibition rate, with an EC50 (concentration for 50% of maximal effect) value of 2.1 mg/L. Propiconazole also showed sufficient inhibitory effects against F. avenaceum, with an EC50 value of 2.6 mg/L. The study provides insights into the newly identified causal agent of wheat FHB in Tibet, China, as well as first pathogen characteristics and promising candidate substances for its management.Entities:
Keywords: Fusarium avenaceum; Tibet; biological characterization; fungicide screening; wheat Fusarium head blight
Year: 2022 PMID: 35992662 PMCID: PMC9389214 DOI: 10.3389/fmicb.2022.941734
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Concentrations of substances used for fungicide sensitivity assays and their China pesticide registration numbers (http://www.chinapesticide.org.cn).
| Fungicide name | Registration number | Active ingredient | Substance concentration (μg/mL) |
| 40% propiconazole EC | PD20093418 | propiconazole | 100, 50, 10, 5, 1 |
| 12.5% myclobutanil EC | PD20086370 | myclobutanil | 100, 50, 10, 5, 1 |
| 40% pyrimethanil SC | PD20060014 | pyrimethanil | 1000, 500, 250, 125, 62.5 |
| 50% thiram WP | PD20093058 | thiram | 500, 300, 150, 30, 15 |
| 80% mancozeb WP | PD20082030 | mancozeb | 300, 100, 50, 25, 12.5 |
| 50% carbendazim WP | PD85150-35 | carbendazim | 6, 3, 1.5, 0.75, 0.38 |
| 70% hymexazol WP | PD20100877 | hymexazol | 200, 100, 50, 25, 12.5 |
FIGURE 1Open field symptoms of wheat Fusarium head blight (A), colony of Fusarium sp. Charlie 779 on potato dextrose agar (PDA) medium (B,C), macroconidia of Fusarium sp. Charlie 779 on septate mycelium (D), macroconidia of Fusarium sp. Charlie 779 (E–G). Scale bars: D–G = 10 μm.
FIGURE 2Phylogenetic analysis of concatenated sequences of the ITS region, EF-1α and RPB-2 obtained from F. avenaceum Charlie 779, F. avenaceum Charlie 782, F. avenaceum Charlie 788, and F. avenaceum Charlie 789 from this study and reference sequences of Fusarium spp. specimens using the maximum likelihood method (1000 bootstrap iterations). Cordyceps javanica CBS 134.22 was used as the outgroup. Bootstrap values are provided next to the respective branches.
FIGURE 3Effects of carbon and nitrogen sources on mycelium growth and conidia germination of F. avenaceum Charlie 779. Colonial growth diameter on different carbon sources (A), conidiospore germination rate on different carbon sources (B), colonial growth diameter on different nitrogen sources (C), conidiospore germination rate on different nitrogen sources (D). Different lowercase letters indicate significant differences (P < 0.05). Data are mean ± SD (n = 3).
FIGURE 4Effects of temperature and photoperiod on mycelium growth and conidia germination of F. avenaceum Charlie 779. Colonial growth diameter under different temperatures (A), conidiospore germination rate under different temperatures (B), colonial growth diameter under different photoperiods (C), conidiospore germination rate under different photoperiods (D). Different lowercase letters indicate significant differences (P < 0.05). Data are mean ± SD (n = 3).
FIGURE 5Effect of UVC irradiation on F. avenaceum Charlie 779. Different lowercase letters indicate significant differences (P < 0.05). Data are mean ± SD (n = 3).
Inhibitory effect of seven fungicides on F. avenaceum Charlie 779.
| Fungicides | Toxic regression equation | EC50(mg⋅L–1) |
| 95% Confidence intervals |
| 40% propiconazole EC | 2.5704 ± 0.15 | 0.9468 | 1.0801–6.1168 | |
| 12.5% myclobutanil EC | 24.6029 ± 0.16 | 0.9768 | 15.7675–38.3892 | |
| 40% pyrimethanil SC | 79.2346 ± 0.21 | 0.9679 | 54.3629–115.4853 | |
| 50% thiram WP | 136.4882 ± 0.31 | 0.9579 | 85.5265–217.8158 | |
| 80% mancozeb WP | 261.3862 ± 0.28 | 0.9292 | 110.1362–620.3476 | |
| 50% carbendazim WP | 2.1385 ± 0.12 | 0.9933 | 1.8629–2.4522 | |
| 70% hymexazol WP | 250.6388 ± 0.33 | 0.9825 | 167.2725–375.5539 |
FIGURE 6Mycelial growth of F. avenaceum Charlie 779 on PDA plates incubated for 7 days in the absence (CK) or presence of different concentrations of propiconazole (A1: 100 μg/mL, A2: 50 μg/mL, A3: 10 μg/mL, A4: 5 μg/mL, A5: 1 μg/mL, A6: CK), myclobutanil (B1: 100 μg/mL, B2: 50 μg/mL, B3: 10 μg/mL, B4: 5 μg/mL, B5: 1 μg/mL, B6: CK), pyrimethanil (C1: 1000 μg/mL, C2: 500 μg/mL, C3: 250 μg/mL, C4: 125 μg/mL, C5: 62.5 μg/mL, C6: CK), thiram (D1: 500 μg/mL, D2: 300 μg/mL, D3: 150 μg/mL, D4: 30 μg/mL, D5: 15 μg/mL, D6: CK), mancozeb (E1: 300 μg/mL, E2: 100 μg/mL, E3: 50 μg/mL, E4: 25 μg/mL, E5: 12.5 μg/mL, E6: CK), carbendazim (F1: 6 μg/mL, F2: 3 μg/mL, F3: 1.5 μg/mL F4: 0.75 μg/mL, F5: 0.38 μg/mL, F6: CK), and hymexazol (G1: 200 μg/mL, G2: 100 μg/mL, G3: 50 μg/mL, G4: 25 μg/mL, G5: 12.5 μg/mL, G6: CK).